The liver plays a key role in detoxifying harmful substances that you may eat, drink, inhale or rub on your skin. Toxic hepatitis is liver inflammation that occurs when your liver is damaged by toxic chemicals, drugs or certain poisonous mushrooms.
The document discusses hepatotoxicity or liver damage. It begins by explaining the liver's role in detoxification and how certain toxins can damage the liver. It then describes the location of the liver and several mechanisms by which chemicals can injure liver cells. Common signs of liver damage include jaundice, fatigue and nausea. Many drugs, toxins, infections and other agents are identified that can cause liver damage through different pathological forms. Treatment focuses on removing the toxic agent and providing supportive care, with transplants as a last resort for severe liver failure.
Hepatotoxicity can be caused by carbon tetrachloride, acetaminophen, ethanol, and aflatoxins. Carbon tetrachloride and aflatoxins cause liver damage through toxic free radicals produced during metabolism. Acetaminophen overwhelms the liver's glutathione reserves, producing a toxic metabolite. Ethanol induces cytochrome P450 enzymes that produce toxic radicals, depleting glutathione and causing lipid peroxidation and cell damage. Clinical signs include nausea, vomiting, mental status changes, and liver failure. Treatment focuses on supportive care, activated charcoal or N-acetylcysteine to prevent further toxicity. There are no antidotes for aflatoxins.
Hepatotoxicity is chemically-driven liver damage caused by drugs or other exposures. The liver plays an important role in metabolizing chemicals and is susceptible to toxicity from overdoses of certain agents or even therapeutic levels sometimes. Hepatotoxicity can be classified as intrinsic or idiosyncratic, with the latter divided into allergic and non-allergic types. The liver is vulnerable to injury from substances due to its unique metabolism and blood flow from the GI tract. Damage to liver cells can release oxidative compounds and disrupt mitochondria, further harming the liver. Common symptoms include jaundice, fatigue, nausea and dark urine. Acetaminophen overdose is a major cause of acute liver failure and often
The document discusses hepatotoxicity, or liver injury caused by chemicals. The liver is the primary site of drug metabolism and many drugs can cause liver damage. Hepatotoxicity can be direct, through overdose, or idiosyncratic, through hypersensitivity reactions. Liver function tests are used to detect abnormalities and extent of damage. Several drugs are described that can cause hepatotoxicity through different mechanisms, such as paracetamol causing centrizonal necrosis, isoniazid causing multilobular necrosis, and halothane causing an immune response through metabolite binding. Regular monitoring of liver enzymes is recommended when taking hepatotoxic drugs.
The document discusses nephrotoxicity in intensive care unit patients, including definitions of acute kidney injury, epidemiology showing AKI occurs in 3.2-67% of ICU patients, and common risk factors such as sepsis, diabetes, and nephrotoxic medications. Mechanisms of nephrotoxicity are described such as effects on intraglomerular hemodynamics, tubular cell toxicity, inflammation, and crystal nephropathy. Biomarkers for early detection of AKI are also mentioned.
Hepatotoxicity, or liver toxicity, can result from anti-tuberculosis (TB) drugs and is known as drug-induced hepatitis (DIH). Patients at high risk include those with pre-existing liver conditions, alcohol use, and advanced TB. Monitoring of liver enzymes is important for high risk patients during TB treatment. Symptoms of DIH include fatigue, nausea, and jaundice. Diagnosis involves abnormal liver enzymes and symptom resolution after stopping anti-TB drugs. Management consists of gradual dose escalation while monitoring for toxicity.
This document discusses hepatotoxicity and liver injury. It covers clinical chemistry markers of liver injury including ALT, SDH, ALP, total bile acids, and bilirubin. It provides examples of clinical chemistry profiles that could indicate hepatocellular injury, cholestasis, or biliary obstruction. Organ weights and histopathological assessments are also important for evaluating hepatotoxicity. The liver has complex cellular architecture and various cell types can be involved in injury responses.
Cardiotoxicity refers to heart damage caused by certain chemotherapy drugs, heavy metals, and other toxins. Three main mechanisms of cardiotoxicity are discussed: interfering with aerobic metabolism in the heart, altering myocardial conduction, and directly damaging heart muscle cells. Symptoms of cardiotoxicity include fatigue, shortness of breath, and swelling. Diagnosis involves physical exams, imaging tests like echocardiograms and MUGA scans, and blood tests. Prevention strategies center around modifying drug treatment plans, using protective medications like dexrazoxane, and controlling risk factors after treatment through medications like ACE inhibitors and beta-blockers.
The document discusses hepatotoxicity or liver damage. It begins by explaining the liver's role in detoxification and how certain toxins can damage the liver. It then describes the location of the liver and several mechanisms by which chemicals can injure liver cells. Common signs of liver damage include jaundice, fatigue and nausea. Many drugs, toxins, infections and other agents are identified that can cause liver damage through different pathological forms. Treatment focuses on removing the toxic agent and providing supportive care, with transplants as a last resort for severe liver failure.
Hepatotoxicity can be caused by carbon tetrachloride, acetaminophen, ethanol, and aflatoxins. Carbon tetrachloride and aflatoxins cause liver damage through toxic free radicals produced during metabolism. Acetaminophen overwhelms the liver's glutathione reserves, producing a toxic metabolite. Ethanol induces cytochrome P450 enzymes that produce toxic radicals, depleting glutathione and causing lipid peroxidation and cell damage. Clinical signs include nausea, vomiting, mental status changes, and liver failure. Treatment focuses on supportive care, activated charcoal or N-acetylcysteine to prevent further toxicity. There are no antidotes for aflatoxins.
Hepatotoxicity is chemically-driven liver damage caused by drugs or other exposures. The liver plays an important role in metabolizing chemicals and is susceptible to toxicity from overdoses of certain agents or even therapeutic levels sometimes. Hepatotoxicity can be classified as intrinsic or idiosyncratic, with the latter divided into allergic and non-allergic types. The liver is vulnerable to injury from substances due to its unique metabolism and blood flow from the GI tract. Damage to liver cells can release oxidative compounds and disrupt mitochondria, further harming the liver. Common symptoms include jaundice, fatigue, nausea and dark urine. Acetaminophen overdose is a major cause of acute liver failure and often
The document discusses hepatotoxicity, or liver injury caused by chemicals. The liver is the primary site of drug metabolism and many drugs can cause liver damage. Hepatotoxicity can be direct, through overdose, or idiosyncratic, through hypersensitivity reactions. Liver function tests are used to detect abnormalities and extent of damage. Several drugs are described that can cause hepatotoxicity through different mechanisms, such as paracetamol causing centrizonal necrosis, isoniazid causing multilobular necrosis, and halothane causing an immune response through metabolite binding. Regular monitoring of liver enzymes is recommended when taking hepatotoxic drugs.
The document discusses nephrotoxicity in intensive care unit patients, including definitions of acute kidney injury, epidemiology showing AKI occurs in 3.2-67% of ICU patients, and common risk factors such as sepsis, diabetes, and nephrotoxic medications. Mechanisms of nephrotoxicity are described such as effects on intraglomerular hemodynamics, tubular cell toxicity, inflammation, and crystal nephropathy. Biomarkers for early detection of AKI are also mentioned.
Hepatotoxicity, or liver toxicity, can result from anti-tuberculosis (TB) drugs and is known as drug-induced hepatitis (DIH). Patients at high risk include those with pre-existing liver conditions, alcohol use, and advanced TB. Monitoring of liver enzymes is important for high risk patients during TB treatment. Symptoms of DIH include fatigue, nausea, and jaundice. Diagnosis involves abnormal liver enzymes and symptom resolution after stopping anti-TB drugs. Management consists of gradual dose escalation while monitoring for toxicity.
This document discusses hepatotoxicity and liver injury. It covers clinical chemistry markers of liver injury including ALT, SDH, ALP, total bile acids, and bilirubin. It provides examples of clinical chemistry profiles that could indicate hepatocellular injury, cholestasis, or biliary obstruction. Organ weights and histopathological assessments are also important for evaluating hepatotoxicity. The liver has complex cellular architecture and various cell types can be involved in injury responses.
Cardiotoxicity refers to heart damage caused by certain chemotherapy drugs, heavy metals, and other toxins. Three main mechanisms of cardiotoxicity are discussed: interfering with aerobic metabolism in the heart, altering myocardial conduction, and directly damaging heart muscle cells. Symptoms of cardiotoxicity include fatigue, shortness of breath, and swelling. Diagnosis involves physical exams, imaging tests like echocardiograms and MUGA scans, and blood tests. Prevention strategies center around modifying drug treatment plans, using protective medications like dexrazoxane, and controlling risk factors after treatment through medications like ACE inhibitors and beta-blockers.
Molecular mechanism of drug induced hepatotoxicityMadhava Priya
This document discusses molecular mechanisms of drug-induced hepatotoxicity. It begins with an introduction to hepatotoxicity and classification into intrinsic and idiosyncratic types. Mechanisms of liver damage include direct cell stress, mitochondrial impairment, and immune reactions. Specific drugs that commonly cause liver injury are also identified, such as acetaminophen, nonsteroidal anti-inflammatory drugs, and isoniazid. Patterns of injury include hepatocellular, cholestatic and mixed. Genetic and non-genetic risk factors also contribute to drug-induced liver damage. Images are also provided showing examples of liver damage.
The document summarizes the different types of liver injury and conditions that can result from toxic effects on the liver. It discusses how chemicals can cause hepatocellular degeneration through damaging mitochondria, plasma membranes, the endoplasmic reticulum, or nucleus of liver cells. This can lead to fibrosis, cirrhosis, or liver tumors over time. Other toxic effects include cholestasis (decreased bile flow), sinusoidal damage, peliosis hepatis (blood-filled cysts), and fatty liver caused by lipid accumulation within liver cells. The document provides examples of chemicals that can induce each type of toxic liver effect.
The document discusses respiratory toxicology and covers several topics:
1. It describes the anatomy and functions of the upper and lower respiratory tract.
2. It explains the mechanisms of lung injury from toxic exposures, including oxidative stress and the role of antioxidants in the lung.
3. It covers several occupational and environmental lung diseases including pulmonary fibrosis, asthma, hypersensitivity pneumonitis, COPD, and lung cancer. It provides details on pulmonary fibrosis and the pathways involved in its development.
This document summarizes the pharmacology of free radicals and their role in various diseases. It discusses how free radicals are generated and the types of free radicals. It then describes how free radicals cause oxidative damage and lead to disorders like diabetes, neurological diseases, cancer, and rheumatoid arthritis. The document also outlines various antioxidants that can protect against free radical damage.
Toxicology is the study of adverse effects of chemicals on living organisms. Key aspects include risk assessment, effects, and exposure. Descriptive toxicology involves toxicity testing while mechanistic toxicology studies physiological and molecular mechanisms of toxicity. Regulatory toxicology determines if chemicals pose acceptable risks. Toxic effects depend on a chemical's absorption, distribution, metabolism, and excretion. Routes of entry include ingestion, inhalation, dermal absorption. Dose, frequency, and duration of exposure impact toxicity. Acute, subacute, subchronic and chronic studies in animals characterize toxicity. Dose-response relationships relate the dose to the response in individuals and populations.
Basic definition and types of toxicology (general, mechanistic, regulatory and descriptive), Regulatory guidelines for conducting toxicity studies OECD, ICH, EPA and Schedule Y OECD principles of Good laboratory practice (GLP)
It's about how toxins affect our body and how our body build as defense mechanism to fight it. Biotransformation is a process when these toxins are converted into useful metabolites.
Toxicokinetics describes how chemicals enter and pass through the body, including absorption, distribution to tissues, biotransformation by the body, and excretion from the body. Key factors that influence toxicity include how well a substance is absorbed, whether it is transformed into more or less toxic metabolites, and how quickly it is removed from the body. Toxicokinetics examines these processes for chemicals at high, toxic doses and is thus important for understanding health risks from chemical exposures.
genotoxicity describes the property of chemical agents that damages the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, whereas not all genotoxic substances are mutagenic
Free radicals are unstable molecules that can damage cells. They are produced through normal cell processes and external factors like pollution and smoking. Reactive oxygen species (ROS) are a type of free radical involving oxygen. ROS can damage DNA and proteins, contributing to cancer development. ROS also cause oxidative stress, an imbalance that promotes carcinogenesis. Antioxidants may help prevent cancer by reducing oxidative stress, though some research indicates controlled oxidative stress through substances like vitamin C can also fight tumors. Curcumin in turmeric has shown anti-cancer effects by down-regulating inflammatory genes and enzymes linked to cancer.
The liver performs many essential functions, including processing nutrients, manufacturing bile, and breaking down toxic substances. Inflammation of the liver can interfere with these processes. Drugs are a common cause of liver injury, with over 900 drugs reported to cause hepatotoxicity. Risk factors for drug-induced liver injury include both drug-related factors like dose and concomitant medications, as well as host-related factors like age, sex, preexisting liver disease, and genetic differences affecting drug metabolism. Common drugs that can damage the liver include antibiotics, antipsychotics, statins, antifungals, antihypertensives, and herbal supplements.
Toxicology is the study of poisons and their effects. There are several branches and types of toxicology. Descriptive toxicology focuses on toxicity testing through hazard identification, dose-response assessment, exposure assessment, and risk characterization. This involves in vitro, in vivo, and in silico testing to evaluate toxic doses, safe exposure levels, and set regulatory standards to protect public health. Mechanistic toxicology studies how toxins interact with living organisms on a molecular level. Regulatory toxicology supports rule making and compliance through standardized testing protocols.
Nephrotoxicology - Toxic Responses of the Kidney Deepmalya Ghosh
Nephrotoxicity is toxicity in the kidneys. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function. There are various forms, and some drugs may affect kidney function in more than one way. Nephrotoxins are substances displaying nephrotoxicity.
This document discusses anti-diarrheal treatments. It introduces that diarrhoea and constipation negatively impact quality of life and health care costs. About 8-9% of people suffer from chronic constipation and 4-5% from chronic diarrhoea. Common causes of diarrhoea include infection, diet, medication, and intestinal disease. Treatment involves rehydration, antimotility agents like loperamide to reduce motility, and antimicrobials for infectious causes. Prevention emphasizes good hygiene and handwashing to avoid spread of infectious diarrhoea.
A brief introduction about Pharmacology of free radicals, generation of free radicals, Antioxidants, Free radicals causing disorders such as cancer diabetes, neuro degenerative disorders such as Parkisonism's Disease
This document discusses toxicity from pesticides, specifically organophosphates and paraquat. It provides information on:
1) Organophosphates are commonly found in household and agricultural pesticides as well as some medical treatments. They work by inhibiting cholinesterase enzymes, leading to excess acetylcholine and symptoms like muscle fasciculations, weakness, and seizures.
2) Paraquat is a herbicide that is toxic when ingested, with a lethal dose between 1-4 grams. It causes lung damage through redox cycling and production of reactive oxygen species.
3) Clinical manifestations of organophosphate toxicity include muscarinic effects like increased salivation as well as nicotinic effects
Hematotoxicity refers to adverse effects of toxicants on blood cells. Drugs can cause decreased red blood cell production by damaging bone marrow, inhibiting DNA synthesis, or incorporating into DNA to trigger cell death. They may also cause megaloblastic anemia by interfering with vitamin B12 or folate, which are needed for DNA synthesis. Additionally, drugs can induce immune-mediated hemolysis through three mechanisms: by acting as haptens to modify red blood cells and stimulate antibody production; forming ternary complexes with red blood cell receptors; or by altering red blood cell membranes to induce autoantibodies.
This document discusses the field of immunotoxicology, which focuses on studying how substances can adversely impact the immune system. It notes that the immune system plays a crucial role in defending the body, and that when compromised, it can increase susceptibility to infections, diseases, and cancer. Immunotoxicology involves in vitro and in vivo studies to assess these impacts. Key applications include drug safety testing, immunotherapy/vaccine development, and risk assessment. The document outlines some common immunotoxic effects and their implications for human health.
Drug induced liver injury (DILI) and HepatotoxicityDr. Ankit Gaur
In this presentation I have tried to explain the defination, Mechanism of drug induced liver injury (DILI) and hepatotoxicity with the help of few examples.
This document discusses drug induced liver injury (DILI), also known as hepatotoxicity. It begins by describing the physiologic functions of the liver and then defines hepatotoxicity as liver damage caused by medicinal agents, chemicals, toxins, or herbal remedies. The document outlines the classification of DILI as either intrinsic or idiosyncratic hepatotoxicity and describes various risk factors. Several specific drugs that can cause liver damage like acetaminophen, ethanol, aflatoxins, and phenytoin are discussed in more detail regarding their mechanisms of toxicity, signs and symptoms, and management approaches.
Molecular mechanism of drug induced hepatotoxicityMadhava Priya
This document discusses molecular mechanisms of drug-induced hepatotoxicity. It begins with an introduction to hepatotoxicity and classification into intrinsic and idiosyncratic types. Mechanisms of liver damage include direct cell stress, mitochondrial impairment, and immune reactions. Specific drugs that commonly cause liver injury are also identified, such as acetaminophen, nonsteroidal anti-inflammatory drugs, and isoniazid. Patterns of injury include hepatocellular, cholestatic and mixed. Genetic and non-genetic risk factors also contribute to drug-induced liver damage. Images are also provided showing examples of liver damage.
The document summarizes the different types of liver injury and conditions that can result from toxic effects on the liver. It discusses how chemicals can cause hepatocellular degeneration through damaging mitochondria, plasma membranes, the endoplasmic reticulum, or nucleus of liver cells. This can lead to fibrosis, cirrhosis, or liver tumors over time. Other toxic effects include cholestasis (decreased bile flow), sinusoidal damage, peliosis hepatis (blood-filled cysts), and fatty liver caused by lipid accumulation within liver cells. The document provides examples of chemicals that can induce each type of toxic liver effect.
The document discusses respiratory toxicology and covers several topics:
1. It describes the anatomy and functions of the upper and lower respiratory tract.
2. It explains the mechanisms of lung injury from toxic exposures, including oxidative stress and the role of antioxidants in the lung.
3. It covers several occupational and environmental lung diseases including pulmonary fibrosis, asthma, hypersensitivity pneumonitis, COPD, and lung cancer. It provides details on pulmonary fibrosis and the pathways involved in its development.
This document summarizes the pharmacology of free radicals and their role in various diseases. It discusses how free radicals are generated and the types of free radicals. It then describes how free radicals cause oxidative damage and lead to disorders like diabetes, neurological diseases, cancer, and rheumatoid arthritis. The document also outlines various antioxidants that can protect against free radical damage.
Toxicology is the study of adverse effects of chemicals on living organisms. Key aspects include risk assessment, effects, and exposure. Descriptive toxicology involves toxicity testing while mechanistic toxicology studies physiological and molecular mechanisms of toxicity. Regulatory toxicology determines if chemicals pose acceptable risks. Toxic effects depend on a chemical's absorption, distribution, metabolism, and excretion. Routes of entry include ingestion, inhalation, dermal absorption. Dose, frequency, and duration of exposure impact toxicity. Acute, subacute, subchronic and chronic studies in animals characterize toxicity. Dose-response relationships relate the dose to the response in individuals and populations.
Basic definition and types of toxicology (general, mechanistic, regulatory and descriptive), Regulatory guidelines for conducting toxicity studies OECD, ICH, EPA and Schedule Y OECD principles of Good laboratory practice (GLP)
It's about how toxins affect our body and how our body build as defense mechanism to fight it. Biotransformation is a process when these toxins are converted into useful metabolites.
Toxicokinetics describes how chemicals enter and pass through the body, including absorption, distribution to tissues, biotransformation by the body, and excretion from the body. Key factors that influence toxicity include how well a substance is absorbed, whether it is transformed into more or less toxic metabolites, and how quickly it is removed from the body. Toxicokinetics examines these processes for chemicals at high, toxic doses and is thus important for understanding health risks from chemical exposures.
genotoxicity describes the property of chemical agents that damages the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, whereas not all genotoxic substances are mutagenic
Free radicals are unstable molecules that can damage cells. They are produced through normal cell processes and external factors like pollution and smoking. Reactive oxygen species (ROS) are a type of free radical involving oxygen. ROS can damage DNA and proteins, contributing to cancer development. ROS also cause oxidative stress, an imbalance that promotes carcinogenesis. Antioxidants may help prevent cancer by reducing oxidative stress, though some research indicates controlled oxidative stress through substances like vitamin C can also fight tumors. Curcumin in turmeric has shown anti-cancer effects by down-regulating inflammatory genes and enzymes linked to cancer.
The liver performs many essential functions, including processing nutrients, manufacturing bile, and breaking down toxic substances. Inflammation of the liver can interfere with these processes. Drugs are a common cause of liver injury, with over 900 drugs reported to cause hepatotoxicity. Risk factors for drug-induced liver injury include both drug-related factors like dose and concomitant medications, as well as host-related factors like age, sex, preexisting liver disease, and genetic differences affecting drug metabolism. Common drugs that can damage the liver include antibiotics, antipsychotics, statins, antifungals, antihypertensives, and herbal supplements.
Toxicology is the study of poisons and their effects. There are several branches and types of toxicology. Descriptive toxicology focuses on toxicity testing through hazard identification, dose-response assessment, exposure assessment, and risk characterization. This involves in vitro, in vivo, and in silico testing to evaluate toxic doses, safe exposure levels, and set regulatory standards to protect public health. Mechanistic toxicology studies how toxins interact with living organisms on a molecular level. Regulatory toxicology supports rule making and compliance through standardized testing protocols.
Nephrotoxicology - Toxic Responses of the Kidney Deepmalya Ghosh
Nephrotoxicity is toxicity in the kidneys. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function. There are various forms, and some drugs may affect kidney function in more than one way. Nephrotoxins are substances displaying nephrotoxicity.
This document discusses anti-diarrheal treatments. It introduces that diarrhoea and constipation negatively impact quality of life and health care costs. About 8-9% of people suffer from chronic constipation and 4-5% from chronic diarrhoea. Common causes of diarrhoea include infection, diet, medication, and intestinal disease. Treatment involves rehydration, antimotility agents like loperamide to reduce motility, and antimicrobials for infectious causes. Prevention emphasizes good hygiene and handwashing to avoid spread of infectious diarrhoea.
A brief introduction about Pharmacology of free radicals, generation of free radicals, Antioxidants, Free radicals causing disorders such as cancer diabetes, neuro degenerative disorders such as Parkisonism's Disease
This document discusses toxicity from pesticides, specifically organophosphates and paraquat. It provides information on:
1) Organophosphates are commonly found in household and agricultural pesticides as well as some medical treatments. They work by inhibiting cholinesterase enzymes, leading to excess acetylcholine and symptoms like muscle fasciculations, weakness, and seizures.
2) Paraquat is a herbicide that is toxic when ingested, with a lethal dose between 1-4 grams. It causes lung damage through redox cycling and production of reactive oxygen species.
3) Clinical manifestations of organophosphate toxicity include muscarinic effects like increased salivation as well as nicotinic effects
Hematotoxicity refers to adverse effects of toxicants on blood cells. Drugs can cause decreased red blood cell production by damaging bone marrow, inhibiting DNA synthesis, or incorporating into DNA to trigger cell death. They may also cause megaloblastic anemia by interfering with vitamin B12 or folate, which are needed for DNA synthesis. Additionally, drugs can induce immune-mediated hemolysis through three mechanisms: by acting as haptens to modify red blood cells and stimulate antibody production; forming ternary complexes with red blood cell receptors; or by altering red blood cell membranes to induce autoantibodies.
This document discusses the field of immunotoxicology, which focuses on studying how substances can adversely impact the immune system. It notes that the immune system plays a crucial role in defending the body, and that when compromised, it can increase susceptibility to infections, diseases, and cancer. Immunotoxicology involves in vitro and in vivo studies to assess these impacts. Key applications include drug safety testing, immunotherapy/vaccine development, and risk assessment. The document outlines some common immunotoxic effects and their implications for human health.
Drug induced liver injury (DILI) and HepatotoxicityDr. Ankit Gaur
In this presentation I have tried to explain the defination, Mechanism of drug induced liver injury (DILI) and hepatotoxicity with the help of few examples.
This document discusses drug induced liver injury (DILI), also known as hepatotoxicity. It begins by describing the physiologic functions of the liver and then defines hepatotoxicity as liver damage caused by medicinal agents, chemicals, toxins, or herbal remedies. The document outlines the classification of DILI as either intrinsic or idiosyncratic hepatotoxicity and describes various risk factors. Several specific drugs that can cause liver damage like acetaminophen, ethanol, aflatoxins, and phenytoin are discussed in more detail regarding their mechanisms of toxicity, signs and symptoms, and management approaches.
This document discusses hepatotoxicity (liver toxicity or damage). It begins by describing the liver's important roles and how an imbalance between protective and aggressive forces can lead to hepatotoxicity from environmental and chemical agents. Common mechanisms of hepatotoxicity include inflammation, immunomodulation, and oxidative stress. Several drugs are described as potential causes of hepatotoxicity, including acetaminophen, carbontetrachloride, ethanol, and some antitubercular drugs. Signs and symptoms of hepatotoxicity and treatments such as supportive care or liver transplant are also summarized. A case study describes hepatotoxicity resulting from antitubercular therapy.
This document discusses the liver's functions in detoxification and drug metabolism. It outlines the liver's two main detoxification pathways, phase 1 and phase 2 reactions, which involve oxidation and conjugation reactions to make substances more water soluble and able to be excreted. Certain dermatology drugs can cause hepatotoxicity through intrinsic or idiosyncratic mechanisms. Ketoconazole and tetracycline are highlighted as drugs that have been associated with hepatotoxicity ranging from mild elevations in liver enzymes to rare cases of fulminant hepatitis.
Abdominal pain has many potential causes, ranging from minor issues to serious illnesses. Doctors determine the cause of abdominal pain through characteristics of the pain, physical examination findings, laboratory and imaging tests, and sometimes surgery. The liver plays an important role in the body and can be damaged by viruses, drugs, alcohol, and other toxins, potentially causing inflammation, scarring, or cancer. Drug-induced liver injury can occur through either predictable dose-related mechanisms or unpredictable reactions in susceptible individuals, and may require stopping the causative drug or transplantation in severe cases.
The document provides an overview of endocrine emergencies including adrenal crisis, diabetic ketoacidosis, and hypoglycemia. It describes the endocrine system and its functions. Adrenal crisis occurs when the adrenal glands cannot produce adequate hormones in response to stress. Diabetic ketoacidosis results from insulin deficiency and excess stress hormones, causing a buildup of ketones in the blood. Assessment, diagnostic testing, nursing diagnoses, and treatment approaches are outlined for these conditions. The goal is to stabilize vital signs and correct fluid, electrolyte, acid-base, and blood glucose imbalances.
This document provides an outline and details regarding chronic liver disease. It begins with an introduction defining chronic liver disease and its causes. Key points include that chronic liver disease lasts over 6 months and can result from viral infections, autoimmune conditions, inherited diseases, cancer or toxin consumption. The document then covers the epidemiology, etiology, pathophysiology, risk factors, complications, signs and symptoms, investigations and treatments of chronic liver disease in greater detail over multiple pages.
This document discusses various types of rodenticides, including their classification, mechanisms of action, clinical signs, diagnosis, and treatment. It covers both inorganic rodenticides such as arsenic, phosphorus, and thallium sulfate as well as organic rodenticides like anticoagulants, fluoroacetate derivatives, vitamin D compounds, ANTU, bromethalin, metaldehyde, and strychnine. For each rodenticide, a brief overview of its mechanism of toxicity, associated clinical signs in poisoned animals, and recommended treatment approaches are provided. The document serves as a comprehensive reference for information on different rodenticide chemicals that are commonly used.
Amiry presented with signs and symptoms consistent with mild alcohol-induced hepatitis superimposed on chronic alcoholic cirrhosis of the liver. This was evidenced by elevated levels of liver enzymes ALT and AST, as well as bilirubin and alkaline phosphatase, indicating hepatic damage. The ratio of ALT to AST was lower than 1, as seen in chronic alcohol-related liver disease rather than acute viral hepatitis. Amiry was advised to abstain from alcohol and improve his nutrition, and was referred to an alcohol rehabilitation program for counseling and treatment.
drug induced liver injury for undergraduatesMohamed Wifi
This document discusses drug-induced liver injury (DILI), the most common cause of abnormal liver function tests. It notes that the liver metabolizes drugs, which can then cause injury through various mechanisms like disrupting calcium homeostasis or inhibiting mitochondrial function. Presentations of DILI may vary from minor abnormalities to fulminant liver failure. Diagnosis involves ruling out other causes and finding a history of drug ingestion. Treatment stops the culprit drug and provides supportive care, while liver transplantation may be necessary in severe cases. Prescribing drugs also requires extra caution for patients with liver disease since their metabolism is impaired.
- Enzymes act as biological catalysts and are important for clinical diagnosis when their levels are abnormal. Important enzymes include AST, ALT, CK, LDH, alkaline phosphatase, and GGT.
- Isoenzymes are genetic variants of enzymes produced in specific tissues, and their patterns can provide information about organ-specific diseases. For example, the three CK isoenzymes indicate heart, brain, or muscle involvement.
- Elevated levels of cardiac enzymes like CK-MB and LDH indicate heart damage as seen in myocardial infarction, while elevated AST, ALT, and GGT suggest liver disease or damage. Alkaline phosphatase is useful for investigating liver and bone diseases
Drugs can harm the liver in a variety of ways. Some medications harm the liver directly, while the liver converts others into compounds that directly or indirectly damage the liver. (This may seem odd given the liver’s critical role in converting hazardous substances to harmless compounds, yet it happens.) Dose-dependent toxicity, idiosyncratic toxicity, and medication allergy are the three forms of liver toxicity.
If enough of a medicine that causes dose-dependent toxicity is consumed, it can cause liver disease in most persons. Overdosing on acetaminophen (Tylenol) is the most common cause of dose-dependent toxicity (discussed later in this article.).
clinical enzymology.final process of indetifying biomolecules in living tissuesKanjoyaKaranja
This document discusses various enzymes that are useful as diagnostic markers. It begins by outlining the objectives of discussing enzymes that reflect organ pathophysiology, with a focus on those useful in diagnosing myocardial infarction, hepatobiliary disorders, and pancreatitis. It then provides definitions of enzymes and discusses their uses as diagnostic markers, reagents, and therapeutics. Specific enzymes are enumerated and examples are given of their clinical uses in diagnosing conditions like myocardial infarction, liver damage, and more. The mechanisms behind increases and decreases in intracellular enzyme levels are also summarized.
This document outlines the course objectives and topics for a pharmacology course for advanced practice nurses. The course covers drugs that influence pain, infection, hematologic disorders, cardiovascular disorders, cancer, and renal disorders. Key topics include therapeutic options for conditions like bacterial infections, congestive heart failure, hypertension, and renal failure. The course evaluation is based on presentations, quizzes, and a final exam. Recommended textbooks are also provided.
This document discusses hepatotoxic drugs and their mechanisms of causing liver damage. It begins by classifying hepatotoxic drugs into intrinsic, idiosyncratic, and chronic categories. It then describes various mechanisms by which drugs can damage the liver, including by forming reactive metabolites, depleting glutathione, and interfering with mitochondrial functions. Specific hepatotoxic drugs are listed for different drug classes. Methods for evaluating hepatotoxicity both in vivo and in vitro are also presented.
This document provides an outline for a presentation on corticosteroids. It begins with an introduction section defining hormones and their functions. It then covers the classification, biosynthesis, physiological actions, and major regulating hormones of the body. The document discusses the adrenal cortex and its secretion of corticosteroids like cortisol and aldosterone. It outlines the history, pharmacokinetics, indications, adverse effects and contraindications of corticosteroid use. The conclusion section suggests the presentation will cover these topics in more depth.
This document provides an overview of drug-induced liver disease (DILD). It defines DILD and discusses its epidemiology and risk factors. Two main mechanisms of hepatotoxicity are described - intrinsic and idiosyncratic. Various types of DILD are outlined including hepatocellular necrosis, steatosis, cholestasis, granulomatous hepatitis, and fibrosis/cirrhosis. Clinical manifestations, investigations, and treatment approaches are summarized. Assessment involves a patient history, liver enzyme levels, biopsy, and nutritional status evaluation. Treatment focuses on diagnosis, drug withdrawal, supportive care, and use of antidotes/corticosteroids if needed.
This document provides information on principles of chemotherapy. It discusses how chemotherapy works by damaging rapidly dividing cells like cancer cells, outlines the cell cycle and phases cells go through when dividing, and explains how chemotherapy targets specific phases to kill cancer cells. It also describes common side effects of chemotherapy like nausea, vomiting, fatigue, bone marrow depression leading to neutropenia, thrombocytopenia and anemia. The document discusses approaches to managing these side effects.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
2. Introduction
Liver plays a key role in detoxifying harmful
substances that you may eat, drink, inhale or rub
on your skin. Toxic hepatitis is liver inflammation
that occurs when your liver is damaged by toxic
chemicals, drugs or certain poisonous
mushrooms.
3. • After absorption into the systemic circulation
and distribution throughout the body :
localization of toxicity in distinct tissues
4.
5. Located in the right upper quadrant of the abdominal
cavity, resting just below the diaphragm. The liver lies to
the right of the stomach and overlies the gallbladder.
6.
7.
8. Factors Influencing Susceptibility
1. Toxicokinetic factors : accumulation of high
concentrations of a xenobiotic
Well-perfused organs or tissues – those that receive
strong blood flow – can also readily accumulate
blood-borne toxicants. These considerations are
especially important for the liver and kidneys –
which as major excretory organs necessarily
receive a high blood flow while also strongly
expressing many xenobiotic transporters.
10. Mechanistic Toxicology
The molecular basis of how chemicals disrupt biological targets, Urs A. Boelsterli
Head, HepaTox Consulting
Pfeffingen, Switzerland
11. Mechanism of Liver Damage
• Due to its unique metabolism and close relationship
with the gastrointestinal tract, the liver is susceptible to
injury from drugs and other substances.
• 75% of blood coming to the liver arrives directly from
gastrointestinal organs and then spleen via portal veins
which bring drugs and xenobiotics in concentrated
form.
• Injury to hepatocyte and bile duct cells lead to
accumulation of bile acid inside liver. This promotes
further liver damage.
12. • Several mechanisms are responsible for either
inducing hepatic injury or worsening the damage
process.
• Many chemicals damage mitochondria, an
intracellular organelle that produce energy.
• Its dysfunction releases excessive amount of
oxidants which in turn injures hepatic cells.
• Non-parenchymal cells such as Kupffer cells, fat
storing stellate cells and leukocytes (i.e.
neutrophil and monocyte) also have role in the
mechanism.
13. Signs and symptoms:
• Yellowing of the skin and whites of the eyes
(jaundice)
• Fatigue
• Loss of appetite
• Nausea and vomiting
• Weight loss
• Dark or tea-colored urine
14. AGENTS WHICH CAUSE OF LIVER DAMAGE
• Toxins - Drugs, Chemicals, Fe,Cu, alpha-1-AT.
• Ischaemia - venous or arterial thrombosis,
hypertension.
• Infection - viral,protozoal, bacterial.
• Immunological - autoimmune, response to infection.
• Cholesterol or triglycerides can accumulate (such as
in steatosis; steat=fat + osis=accumulation).
• Obstruction of bile flow (such as in cholestasis:
chole=bile + stasis=standing).
15. Drugs causing Liver damage
• Acetaminophen:-
(Paracetamol, also known
by the brand name Tylenol
and Panadol) is usually well
tolerated in prescribed dose
but overdose is the most
common cause of drug
induced liver disease and
acute liver failure
worldwide. Acetaminophen (3D structure)
overdose is the most common cause
of drug induced liver disease
16. Nonsteroidal anti-inflammatory drugs- Aspirin,
ibuprofen, sulindac, phenylbutazone, piroxicam,
diclofenac and indomethacin.
Glucocorticoids- Glucocorticoids are so named due to
their effect on carbohydrate metabolism. They promote
glycogen storage in liver. The classical effect of prolonged
use both in adult and pediatric population is steatosis.
Isoniazid- Isoniazide (INH) is one of the most commonly
used drug for tuberculosis; it is associated with mild
elevation of liver enzymes in up to 20% of patients and
severe hepatotoxicity in 1-2% of patients
17. • Natural products- Amanita
mushroom, particularly the
destroying angels, aflatoxins.
• Industrial toxin- Arsenic,
Carbon tetraChloride, Vinyl
Chloride.
• Herbal and alternative
remedies- Ackee fruit,
Camphor, Pyrrolizidine
alkaloids, Valerian, Comfrey
(often used in herbal tea).
18. Forms of liver toxicity:-
Tissue Necrosis-
Hepatitis- Disease of the liver causing
inflammation.
Cholestasis- Cholestasis is a condition where bile
cannot flow from the liver to the duodenum.
Steatosis- Steatosis is a condition characterized
by the build up of fat within the liver, sometimes
triggering inflammation of the liver
19. • Granuloma- A granuloma is one of a number
of forms of localized nodular inflammation
found in tissues.
• Vascular lesions- They result from injury to
the vascular endothelium.
• Neoplasm- Neoplasm or tumor, tissue
composed of cells that grow in an abnormal
way.
20. Complications:-
Except for gallstone disease and some viral infections
such as Hepatitis A and infectious mononucleosis, most
liver diseases are managed and not cured.
Liver disease can progress to cirrhosis and liver failure.
Associated complications may include increased risk of
bleeding and infection, malnutrition and weight loss, and
decreased cognitive function.
Some liver diseases are associated with an increased risk
for developing liver cancer
22. Treatment:-
No specific treatment exists for most kinds of toxic
hepatitis
For most other cases of drug-induced toxic hepatitis,
stopping the medication is the only treatment.
Other treatments include:
Supportive therapy. People with severe symptoms are
likely to receive supportive therapy in the hospital,
including intravenous fluids and medication to relieve
nausea and vomiting.
Liver transplant. When liver function is severely impaired,
a liver transplant may be the only option for some people
32. Acetaminophen’s Chemistry
• Molecular formula:
– C8-H9-N-O2
• Molecular weight: 151.16
• Color: White
• Odor: odorless
• Taste: slightly bitter taste
• Melting point: 169-
170.5°C
• Dissociation Constant:
pka= 9.38
Acetaminophen: ChemID Plus Lite. National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1 Apr. 1983. Web. 8
Oct. 2010. http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?
objectHandle=Search&actionHandle=getAll3DMViewFiles&nextPage=jsp%2Fcommon%2FChemFull.jsp%3FcalledFrom
%3Dlite&chemid=0000103902&formatType=_3D (both image and data)
33. Mechanism of Action of
Acetaminophen
• Selectively reduces cyclo-oxygenase products
in the CNS and PNS
– Principally prostaglandins (PG) E2
– As well as other prostaglandins
– Thromboxanes
– Prostacyclin
Lucas, Ruth, Warner, T.D., Vojnovic, I., and Mitchell, J.A. “Cellular Mechanism of Acetaminophen: Role of Cyclo-oxygenase.” The
FASEB Journal 18 (10 Feb. 2005). Web 6 Oct. 2010.
34. Acetaminophen Mechanism of
Toxicity
• APAP is metabolized in the liver
– By glucuronidation and sulfation
• At therapeutic doses
– 4% converted by the cytochrome P450 into the
reactive toxic intermediate N-acetyl-p-
benzoquinoneimine (NAPQI)
– NAPQI becomes nontoxic when it binds to
glutathione
Moling, Oswald, Cairon, Elena, Rimenti, Giovanni, et al. “Case Report: Severe Hepatotoxicity After Therapeutic Doses of
Acetaminophen.” Clinical Therapeutics 28.5 (May 2006) : 755-760. Web. 6 Oct. 2010.
35. Acetaminophen Mechanism of
Toxicity
• APAP overdose occurs due to
– CYP enzyme induction
– Glutathione depletion
– Inhibition of glucuronidation
• If any of the previous actions occur
– NAPQI is no longer able to bind to glutathione
– Instead, NAPQI reacts with the cysteine group of
hepatocellular proteins
– Leads to the loss of cell function and cell death
Moling, Oswald, Cairon, Elena, Rimenti, Giovanni, et al. “Case Report: Severe Hepatotoxicity After Therapeutic Doses of
Acetaminophen.” Clinical Therapeutics 28.5 (May 2006) : 755-760. Web. 6 Oct. 2010.
36. Acetaminophen’s Indication
• Analgesic, non-narcotic
• Relives mild to moderate pain
• Reduces fever
• Provides only symptomatic relief
• Minimum anti-inflammatory activity
• Does not relieve redness, swelling, or stiffness due to
arthritis
• Should not be used as a substitute for aspirin or other
salicylates or NSAIDS the treatment of rheumatoid
arthritis
• Is indicated for the relief of pain due to mild
osteoarthritis
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
37. Acetaminophen’s Indication
• May be used when aspirin therapy is
contraindicated or inadvisable
• Used to treat acute-tension type headaches
with mild to moderate pain
• Used for mild to moderate myalgia, arthralgia,
chronic pain of cancer, and postoperative pain
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
39. Routes of Exposure
• Most common
– Ingestion as an analgesic
for relief from pain
• Other routes
– Inhalation and dermal
contact
• Usually by workers that
work at places that APAP
is produced or used
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
Image taken from
<http://www.clipartheaven.com/show/clipart/health_&_medical/car
toons/taking_medicine_2-gif.html>
40. Neonatal Case: Route of
Administration
• APAP was prescribed by the doctor for the 4-day old
term male infant for pain due to circumcision
– Every 4h since his circumcision on the 2nd
day of his birth
• Total amount of APAP received by the patient
– 80mg (26mg/kg) every 4h for the first 24h
• This was while he was still in the hospital
– 10mg (13mg/kg) every 4h for the next 2 days
• This was after he was discharged and taken home
• APAP concentration measured 16h after his last dose
at home
– 109.8µg/ml (therapeutic range 10-30µg/ml)
Walls, L, CF Baker, and S Sarkar. “Perinatal/Neonatal Case Presentation: Acetaminophen-induced Hepatic Failure with
Encephalopathy in a Newborn.” Journal of Perinatology 27.2 (Feb. 2007): 133-136. Web. 6 Oct. 2010.
41. Multiple Risk Case: Route of
Administration
• APAP was self administered by the patient for
a rise in temperature to 40°C
– 1000mg QID for 4 days
– And once during the morning before his admission
to the hospital
• He also took
– Single dose of twelve 2mg tablets of
buprenorphine
• For withdrawal symptoms
Moling, Oswald, Cairon, Elena, Rimenti, Giovanni, et al. “Case Report: Severe Hepatotoxicity After Therapeutic Doses of
Acetaminophen.” Clinical Therapeutics 28.5 (May 2006) : 755-760. Web. 6 Oct. 2010.
42. Populations at Risk
• Patients with sulfite sensitivity
– Some commercially available formulation contain
sulfites
– May cause allergic-type reactions
• Anaphylaxis
• Life threatening or less sever asthmatic episode
– This is a low occurrence incidence and usually
occurs in asthmatic individuals
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
43. Source: WATSON, WILLIAM. "2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System"
AMERICAN JOURNAL OF EMERGENCY MEDICINE 22.5 (2004): 386. Web. 8 Oct 2010. <http://www.aapcc.org/dnn/Portals/0/AJEM%20-
%20AAPCC%20Annual%20Report%202003.pdf>
44. Multiple Risk Case
• 85kg male
• Asymptomatic HIV
• HBV infection
• HCV infection
• 20 packs of cigarette daily
• 1L of beer daily
• IV heroin (4 months prior to his hospital visit)
• For the last 4 days before the hospitalization
– Pt starved due to
• Fever
• Malaise
• Nausea
Moling, Oswald, Cairon, Elena, Rimenti, Giovanni, et al. “Case Report: Severe Hepatotoxicity After Therapeutic Doses of
Acetaminophen.” Clinical Therapeutics 28.5 (May 2006) : 755-760. Web. 6 Oct. 2010.
45. Biological Fate
- Usually Acetaminophen is absorbed
within 1 hour (IR products, 2 hours for EC
products) after ingestion, but many factors
can change this:
•Drugs affecting GI motility
•If the drug itself was taken in another
dosage form such as elixirs or liquid
preparation
•If the tablet was cut or broken before
injection
- In children, the rate of absorption is
drastically increased. However their
chances of hepatotoxicity is lower (unclear)
- Peak Serum concentrations of acute
overdose may be delayed by as much as 4
hours
Acetaminohen Structure: Harrison, Kari. "Acetaminophen." 3D Chem. 3D Chem, 01 Jun
2003. Web. 8 Oct 2010. <http://www.3dchem.com/molecules.asp?ID=9>.
NAPQI Structure: "N-acetyl-p-benzo-quinone imine ." N-Acetyl-p-benzochinonimin . Web. 8
Oct 2010. <http://commons.wikimedia.org/wiki/File:N-Acetyl-p-benzochinonimin.svg>.
Acetaminophen
(APAP)
N-acetyl-p-benzo-quinone imine
(NAPQI)
Acetaminophen: Toxicology Data Network
(TOXNET). National Library of Medicine
:Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010.
<http://toxnet.nlm.nih.gov/cgi-
bin/sis/search/f?./temp/~ZSagYF:1>
46. Biological Fate (Con’t)
• Acetaminophen is metabolized in
the liver in adults primarily (85-
90%) by direct sulfation (~30% )
and glucuronidation (~65-75%).
• Another 5% is excreted
unchanged in the urine while 5-
10% is metabolized by CYP 450
enzymes 2E1, 1A2 and 3A4.
• However N-acetyl-p-
quinoneimine metabolite is
formed by oxidation via CYP
enzymes and it can cause
hepatotoxicity in acute doses
(necrosis occurs)
• NAPQI is changed via glutathione
conjugation and excreted as
Mercapturic acid
Excretion differences of Acetaminophen in
Children vs. Adults
Source: Kociancic, Todd.
"http://www.medscape.com/viewarticle/459187_2." Medscape Pharmacist.
Pharmacotherapy Publications Inc, 2003. Web. 8 Oct 2010.
<http://www.medscape.com/viewarticle/459187_2>.
Acetaminophen: Toxicology Data Network (TOXNET).
National Library of Medicine :Hazardous Substances Data
Bank (HSDA), 1 Apr. 1983. Web. 8 Oct. 2010.
<http://toxnet.nlm.nih.gov/cgi-
47. Children vs. Adults
• Children have faster turnover
rate of glutathione or increased
sulphate conjugation, hence why
they might be less likely to get
hepatotoxicity but decreased
glucuronidation capacity
• Most cases of child-toxicity are
due to unintentional overdose of
drug with a therapeutic intent
• Phenylketonuria patients need to
be careful with Children’s
acetaminophen
• Use weight-based dosing and
calibrated dosing equipment!!
• Toxicity data in adults with liver
damage is unclear
• Factors discussed previously can
predispose adults and children
for higher risk of liver damage
• Patients taking anti-coagulants
should be monitored for INR
levels
• Renal function is another issue
most people forget to address
• Fasting patients are high risk
since 4g-10g can easily induce
hepatotoxicity
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
48. General Effects of Toxicity
• The classic effect is
hepatotoxicity, can lead to
jaundice and increased liver
enzymes in the blood
• Liver failure can result in
encephalopathy, confusion,
coma and ultimately leading
to death
• Treatment after acute liver
failure can involve liver
transplant
• Transient azotemia in most
patients, renal failure in
some patients
• Hypoglycemia and
decreased glucose
tolerance in patients (2-4
days after hepatic failure)
• Metabolic acidosis and
alkalosis are reported (dec
epinephrine response)
• Cerebral edema &
nonspecific myocardial
depression have also been
observed
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
49. Effects Continued
• Pulmonary Edema
• Myocardial (EKG
changes and CPK M&B
changes)
• Nausea & Vomiting
followed by abdominal
pain and hepatotoxicity
• Hyperamylasemia may
be detected in some
cases (Pancreatitis)
• Proteinuria and Renal
damage (tubular
necrosis)
• Hypophosphatemia
reported in patients
with overdose
regardless of liver
damage (non
survivors?)
• Hemolysis in patients
with G6PDH
Acetaminophen: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), 1
Apr. 1983. Web. 8 Oct. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~ZSagYF:1>
50. CYP 2E1 Role in Toxicity
Source: "Determination of APAP-induced liver and
kidney injury in wild-type and Cyp2e1-null mice."
Identification of Novel Toxicity-associated
Metabolites by Metabolomics and Mass Isotopomer
Analysis of Acetaminophen Metabolism in Wild-type
and Cyp2e1-null Mice. Web. 12 Oct 2010.
<http://www.jbc.org/content/283/8/4543/F1.large.jpg>
.
51. Symptoms
• Occur in Four Stages
• Usually minor until 48
hours post-exposure
• May not exist for mild
poisoning
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image taken from http://4.bp.blogspot.com/_EQiYy5Raips/TEWsm9LlYPI/AAAAAAAAAcA/KmfU6fMU0N4/s1600/sick_girl.jpg 08 Oct. 2010
52. Stage 1
• Within 24 hours
• Mild
• Nausea, Vomiting,
Anorexia
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image taken from http://3.bp.blogspot.com/_w5baxtfyh30/THFIB3T8qvI/AAAAAAAAAZg/sdhqVxj4h60/s1600/nausea.gif. 08 Oct. 2010
53. Stage 2
• 24-48 hours after
exposure
• Right upper quadrant
abdominal pain
• Elevated AST, ALT,
Bilirubin levels are
also possible
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image taken from http://anatomy.med.umich.edu/surface/abdomen/ab_quadrant.jpeg. 08 Oct. 2010
54. Stage 3
• 72-96 Hours after
exposure
• Vomitting
• Peaking of AST, ALT
levels
• In severe cases
symptoms of
Pancreatitis and
Nephrotoxicity
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image 1 taken from http://www.merlehamburger.net/images/pancreas2.jpg. 08 Oct. 2010.
Image 2 taken from http://www.osovo.com/diagram/diagram-of-kidney.gif. 08 Oct. 2010.
55. Stage 4
• Over 5 days after
exposure
• Two things can occur
– Resolution of liver
toxicity
– Multiple organ failure
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image taken from http://www.knowyourgut.com/wp-content/uploads/2009/07/emergency-room.jpg. 08 Oct. 2010
56. Other Consequences of Severe Toxicity
• Hepatic Encephalopathy
– Grade III – Confusion
– Grade IV – Coma
• Hypoglycemia
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08
Oct. 2010. http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
57. Neonatal Case
• Symptoms present after being admitted to the
hospital
– Sleepy /lethargic
– Fed poorly
– Vomited about 10 times in the last 24 hrs
– Moderately dehydrated
– Poorly responsive to stimulation
Walls, L, CF Baker, and S Sarkar. “Perinatal/Neonatal Case Presentation: Acetaminophen-induced Hepatic Failure with
Encephalopathy in a Newborn.” Journal of Perinatology 27.2 (Feb. 2007): 133-136. Web. 6 Oct. 2010.
58. Multiple Risk Case
• Symptoms present upon reporting to the ER
– Extreme weakness
– Malaise
Moling, Oswald, Cairon, Elena, Rimenti, Giovanni, et al. “Case Report: Severe Hepatotoxicity After Therapeutic Doses of
Acetaminophen.” Clinical Therapeutics 28.5 (May 2006) : 755-760. Web. 6 Oct. 2010.
59. Patient Assessment (Labs)
Within 8 Hours of Overdose
• Lab test to determine serum
acetaminophen levels
• Begin Acetylcysteine or other
charcoal treatment as
recommended by guidelines
• If Acetylcysteine treatment is
given, continue to monitor
renal, liver and serum
electrolyte levels
• If needed, re-test serum
acetaminophen levels (should
see an improvement)
Unknown Time of overdose
• Lab tests to determine serum
acetaminophen levels
• Patient INR levels, Liver
enzyme levels, liver function,
renal function (SrCl) and
serum electrolyte levels
should be determined
• Treat with Acetylcysteine if
serum Acetaminophen or
transaminases (ALT, AST) are
detected
60. Lab Values
Measure Indicative of Toxicity
Serum Creatinine (SrCr) Elevated over 3.4 mg/dL
Creatinine Clearance (CrCl) Lowered
International Normalized Ratio (INR) Elevated
Prothrombin Time (PT) Elevated over 100 seconds
Aspartate Aminotransferase (AST) Elevated
Alanine Transaminase (ALT) Elevated
Billirubin Elevated over 18 mg/dL
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Schaefer, Jeffrey P. "Acetaminophen Intoxication." Dr. Jeffrey P Schaefer, 14 Oct. 2007. Web. 10 Oct. 2010.
<http://dr.schaeferville.com/presentations/20071014_acetaminophen_intoxication.pdf>.
61. Treatment
• Two treatment methods
– Activated Charcoal
• Works by adsorbing
unabsorbed drug in the
stomach
– N-acetylcysteine (NAC)
• Works by increasing hepatic
glutathione stores.
Schaefer, Jeffrey P. "Acetaminophen Intoxication." Dr. Jeffrey P Schaefer, 14 Oct. 2007. Web. 10 Oct. 2010.
<http://dr.schaeferville.com/presentations/20071014_acetaminophen_intoxication.pdf>.
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image 1 taken from http://wellnessmama.files.wordpress.com/2009/11/221834-main_full.jpg. 10 Oct. 2010
Image 2 taken from https://www.lifeluxure.com/images/N-Acetyl-Cysteine.jpg. 10 Oct. 2010
62. Activated Charcoal
• Must be initiated
within four hours of
exposure
• Can be given after 4
hours if an extended
release formulation
of acetaminophen
was ingested
Schaefer, Jeffrey P. "Acetaminophen Intoxication." Dr. Jeffrey P Schaefer, 14 Oct. 2007. Web. 10 Oct. 2010.
<http://dr.schaeferville.com/presentations/20071014_acetaminophen_intoxication.pdf>.
DRUGDEX® System . Thomson Reuters (Healthcare) Inc. http://www.thomsonhc.com. 10 Oct. 2010
Image 1 taken from http://www.nynaturalhealthcenter.com/vitamins/images/activatedcharcoal1.jpg. 10 Oct. 2010
Given at 1-2 grams per Kilogram
Body Weight
63. N-Acetylcysteine
• Must be initiated 8-10 hours
after ingestion
• Benefit questionable >24 hours
• Oral
– Loading dose 140 mg/kg
– Maintenance dose 70 mg/kg every 4
hours for 17 doses
• Intravenous (IV)
– Loading dose 150 mg/kg in 200ml
D5W over 15 minutes
– Followed by 50 mg/kg in 500 cc D5W
infused over 4 hours, then 100 mg/kg
in 1,000 cc D5W infused over the
remaining 16 hours.
"Focus On: Acetaminophen Toxicity and Treatment." American College of Emergency Physicians. Web. 08 Oct. 2010.
<http://www.acep.org/publications.aspx?id=26830>.
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
Image 1 taken from http://www.kingguide.com/images/vials.gif. 08 Oct. 2010.
64. Comparison of Routes of
Administration
Oral (PO) Intravenous (IV)
Low Cost High Cost
Long duration of therapy (72 hours) Shorter duration of therapy (20 hours)
Adverse Effects are minimal
Usually Nausea and Emesis
More Adverse Effects
AnaphylactOID Reaction (No IgE action)
Vomiting <1hr post-administration requires
the dose to be readministered
Adverse effects more common in asthmatic
patients
Poor palatability Rash, Itching, Bronchospasm, Tachycardia,
Hypotension
Patients that are not candidates for oral
route have to use IV
Symptoms are usually mild
(severe in ~1% of cases)
Ex. Neonates, Patients with altered mental
status, GI bleed, repeat vomiting etc.
Hold infusion and re-challenge with lower
dose (Low recurrence rate)
"Focus On: Acetaminophen Toxicity and Treatment." American College of Emergency Physicians. Web. 08 Oct. 2010.
<http://www.acep.org/publications.aspx?id=26830>.
O'Malley, Gerald F. "Acetaminophen Poisoning: Poisoning: Merck Manual Professional." Merck & Co., Inc. Merck & Co. Web. 08 Oct. 2010.
http://www.merck.com/mmpe/sec21/ch326/ch326c.html>.
"Clinical Policy: Critical Issues in the Management of Patients Presenting to the Emergency Department with Acetaminophen Overdose." National Guideline C
Clearinghouse. US Department of Health and Human Services, 15 Feb. 2008. Web. 10 Oct. 2010.
<http://www.guideline.gov/content.aspx?id=11428&search=acetaminophen+overdose>.
65. Patient Education
• Patient should not take over 4
grams of Acetaminophen/day.
• Threshold may be lower for
patients with liver disease or
cirrhosis
• Increased risk of
hepatotoxicity with chronic
alcohol use
• Patient should be careful when
taking numerous products
containing Acetaminophen
– Ideally this should be avoided
DRUGDEX® System . Thomson Reuters (Healthcare) Inc. http://www.thomsonhc.com. 10 Oct. 2010
Image 1 taken from http://blog.oregonlive.com/health_impact/2009/07/acetaminophen.JPG. 10 Oct. 2010
66. Acetaminophen Containing Products
• Prescription Drugs
– Darvocet®
– Endocet®
– Fioricet®
– Hycotab
– Hydrocet®
– Hydrocodone Bitartrate
– Lortab®
– Percocet®
– Phenaphen®
– Sedapap®
– Tapanol®
– Ultracet®
– Vicodin®
– Zydone®
• Over the Counter Drugs
– Actifed®
– Anacin®
– Benadryl®
– Cepacol®
– Contac®
– Coricidin®
– Dayquil®
– Dimetapp®
– Dristan®
– Elixir®
– Excedrin®
– Feverall®
– Formula 44®
– Goody’s® Powders
– Liquiprin®
– Midol®
– Nyquil®
– Panadol®
Robitussin®
Saint
Joseph®
Aspirin-Free
Singlet®
Sinutab®
Sudafed®
Theraflu®
Triaminic®
TYLENOL®
Brand
Products
Vanquish®
Vicks®
Zicam®These are only the commonly used products.
There are many other products available.
"Acetaminophen (APAP) & Liver Damage." TYLENOL® - The Official Website for All TYLENOL® Products. McNeil INC. Web. 08 Oct. 2010.
<http://www.tylenol.com/page.jhtml?id=tylenol/news/acetaminophen_liver_damage.inc>.
Point out pka to show that it can irritate the stomach and it can be enteric coated
PGE2 are mediators of fever, pain, and inflammation
Basically there really is not any major ways that the general population may be exposed to APAP other then ingesting it. We have to remember that this is a drug and it usually comes in oral form. What causes it to be so significant is the rate of exposure that is seen in the general population. Since as we said before it is something that is a common OTC drug, most household do have it in their homes at all time.
CPK – Creatine Phospho Kinase levels
Basically what we see are the classical GI irritation but no major notable signs
Tenderness and abdominal pain, enlarged liver
Jaundice, GI bleeding, edemas, multi organ failures
No apparently physical symptoms but heavy liver damage or coma or death.
- Stage 4 patients have hepatic histological changes such as increased CYP2E1 enzymes which may last for up to 3 months
Now the lab values are really according to who the patient is and this will be further explained and explored as we talk about the individual cases.
Just as a side note: I am sure many of u have heard or even watched the tv show “House MD” and kn that he was addicted to Vicodin. Vicodin of course is a narcotic analgesic that is a combination of hydrocodone and paracetamol.
While something like Vicodin is much more addicting, acetaminophen alone can be just as addicting. Its just that using acetaminophen to alleviate pain has become so common that many people underestimate it.